IRIS
RIZZI, Federica Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.899
AS - Asia 4.967
EU - Europa 3.656
SA - Sud America 583
AF - Africa 230
Continente sconosciuto - Info sul continente non disponibili 176
OC - Oceania 13
Totale 15.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.720
SG - Singapore 1.558
CN - Cina 1.336
VN - Vietnam 1.005
IT - Italia 913
IE - Irlanda 585
BR - Brasile 439
SE - Svezia 432
FI - Finlandia 363
HK - Hong Kong 327
DE - Germania 286
UA - Ucraina 232
FR - Francia 206
BD - Bangladesh 188
ZA - Sudafrica 148
NL - Olanda 136
RO - Romania 121
CA - Canada 120
TR - Turchia 103
IN - India 94
GB - Regno Unito 93
AT - Austria 80
RU - Federazione Russa 66
AR - Argentina 52
KR - Corea 41
ID - Indonesia 40
IR - Iran 40
JP - Giappone 34
IQ - Iraq 31
BE - Belgio 30
PH - Filippine 29
MX - Messico 25
CO - Colombia 22
PK - Pakistan 22
EC - Ecuador 20
CZ - Repubblica Ceca 19
ES - Italia 19
CI - Costa d'Avorio 18
PL - Polonia 18
TH - Thailandia 17
UZ - Uzbekistan 14
VE - Venezuela 14
AE - Emirati Arabi Uniti 11
CL - Cile 11
SA - Arabia Saudita 11
MA - Marocco 10
PY - Paraguay 10
TW - Taiwan 10
AU - Australia 9
AZ - Azerbaigian 9
KE - Kenya 9
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
PE - Perù 6
PT - Portogallo 6
TN - Tunisia 6
AL - Albania 5
EU - Europa 5
HN - Honduras 5
UY - Uruguay 5
BG - Bulgaria 4
CR - Costa Rica 4
EE - Estonia 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
PR - Porto Rico 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
NG - Nigeria 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BI - Burundi 2
DK - Danimarca 2
GR - Grecia 2
NI - Nicaragua 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
GA - Gabon 1
Totale 15.340
Salva come PNG Salva come JPEG
Città #
Singapore 799
Ashburn 757
Dublin 580
Chandler 520
San Jose 440
Santa Clara 377
Dallas 322
Hong Kong 307
Ho Chi Minh City 287
Jacksonville 273
Beijing 262
Parma 243
Council Bluffs 242
Ann Arbor 230
Dearborn 211
Hanoi 211
Boardman 148
Nanjing 145
Johannesburg 141
Focsani 112
Shanghai 107
Los Angeles 102
Princeton 93
San Mateo 91
Lauterbourg 85
New York 82
Izmir 72
Toronto 63
Vienna 63
Munich 62
Jinan 60
Buffalo 49
Shenyang 49
São Paulo 49
Da Nang 48
Hefei 47
Wilmington 47
Marseille 46
Helsinki 45
Haiphong 43
Bologna 41
Milan 40
Hebei 39
Moscow 38
Nanchang 38
Turku 36
Des Moines 35
Columbus 34
Rome 34
Guangzhou 33
Changsha 32
Chicago 32
Tokyo 31
Brussels 28
Nuremberg 28
Kunming 27
Leawood 27
London 27
Frankfurt am Main 25
Fremont 25
Zhengzhou 25
Reggio Emilia 24
Jakarta 23
Haikou 22
The Dalles 21
Tianjin 21
Houston 20
Seattle 20
Brooklyn 19
Abidjan 18
Falls Church 18
Jiaxing 18
Redmond 18
Biên Hòa 17
Hải Dương 17
Augusta 16
Dong Ket 16
Montreal 16
Seoul 16
Belo Horizonte 15
Modena 15
Stockholm 15
Atlanta 14
Baghdad 14
Orem 14
Phoenix 14
Mumbai 13
Piacenza 13
Taiyuan 13
Taizhou 13
Trieste 13
Warsaw 13
Ardabil 12
Ardea 12
Denver 12
Rio de Janeiro 12
Tashkent 12
Amsterdam 11
Bremen 11
Chennai 11
Totale 9.197
Salva come PNG Salva come JPEG
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 484
Ionizing Radiation Effects on Hs 578Bst Microtubules 313
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 313
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 301
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 261
Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies 252
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 243
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 233
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 230
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 215
SERS-based methods for the detection of genomic biomarkers of cancer 206
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 204
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 202
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 202
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 197
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 194
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 193
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 192
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 190
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 186
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 178
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 176
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 174
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 173
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 170
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 170
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 167
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 166
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 164
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 164
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 162
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 161
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 161
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 161
Effects of Clusterin knock down on prostate cancer progression in the tramp model 160
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 155
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 155
Anticancer activity of green tea polyphenols in prostate gland 152
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 152
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 152
Clusterin is epigenetically repressed in human prostate cancer cells 150
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 150
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 149
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 149
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 149
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 148
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 147
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 147
Clusterin (CLU): From one gene and two transcripts to many proteins 146
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 146
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 143
Chemoprevention of human prostate cancer by oral administration of green tea catechins 143
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 140
Clusterin (CLU) and lung cancer 139
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 139
Clusterin (CLU) and prostate cancer 138
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 135
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 134
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 132
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 130
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 128
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 127
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 122
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 122
Clusterin is epigenetically repressed in human prostate cancer. 122
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 122
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 120
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 115
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 115
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 115
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 114
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 114
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 114
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 111
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 111
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 111
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 110
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 109
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 109
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 108
Il tè verde nella chemoprevenzione oncologica 107
Green tea polyphenols and prostate cancer chemoprevention 105
Redox Status and Proteostasis in Ageing and Disease 103
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 103
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 100
Nuclear CLU (nCLU) and the fate of the cell 100
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 100
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 99
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 98
Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives? 96
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 96
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 89
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 88
Espressione in forma ricombinante di differenti forme di clusterina 86
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 84
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 83
Targeting clusterin in prostate cancer 81
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 80
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 80
Prognostic role of clusterin in resected adenocarcinomas of the lung 79
Totale 15.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022549 0 46 8 16 29 16 71 75 26 44 67 151
2022/20232.055 186 208 155 173 137 232 22 137 669 14 82 40
2023/2024746 63 53 30 24 88 148 49 43 23 54 53 118
2024/20252.768 62 148 133 189 289 312 109 103 342 204 442 435
2025/20265.809 570 403 669 467 790 286 483 205 1.057 455 243 181
2026/2027324 150 174 0 0 0 0 0 0 0 0 0 0
Totale 15.524